Overview

Ertapenem Pharmacokinetics in Patients in Continuous Ambulatory Peritoneal Dialysis

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to characterize the pharmacokinetic profile of ertapenem during continuous ambulatory peritoneal dialysis (CAPD).
Phase:
Phase 4
Details
Lead Sponsor:
Albany College of Pharmacy and Health Sciences
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Ertapenem